Identifying patients at risk for sepsis using advanced data analysis
Characterizing patients at risk for sepsis through Big Data
This study is working on improving a smart computer system that helps doctors predict sepsis and its effects on organs, especially for patients in critical condition, so they can provide better care and prevent serious complications.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10668998 on NIH RePORTER |
What this research studies
This research aims to enhance an existing artificial intelligence system that predicts sepsis by analyzing clinical data from electronic medical records. It focuses on forecasting the type and sequence of organ failures associated with sepsis, particularly in patients experiencing shock, acute respiratory failure, and acute kidney injury. By incorporating high-resolution cardiovascular data and metabolomics, the study seeks to improve the accuracy of risk assessments for patients in critical care settings. The findings could lead to better-targeted interventions for those at risk of developing severe complications from sepsis.
Who could benefit from this research
Good fit: Ideal candidates for this research include critically ill patients in intensive care units who are at risk for sepsis and related organ failures.
Not a fit: Patients who are not critically ill or do not have conditions that predispose them to sepsis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and intervention for patients at risk of sepsis, potentially saving lives and improving outcomes.
How similar studies have performed: Other research has shown promise in using data-driven approaches and artificial intelligence to predict sepsis, indicating that this methodology has potential for success.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Holder, Andre L — Emory University
- Study coordinator: Holder, Andre L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.